Axiom Investors’s NEVRO CORP. NVRO Stock Holding History

Axiom Investors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-33,464	Closed	-$3.04M	–	158
2017 Q3	$3.04M	Buy	33,464 +4,782	+17%	+$409K	0.07%	105
2017 Q2	$2.13M	Sell	28,682 -3,857	-12%	-$309K	0.05%	120
2017 Q1	$3.05M	Buy	+32,539	New	+$2.95M	0.08%	100

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Axiom Investors's NVRO Position: Q4 2017 in Review

Axiom Investors sold out of NEVRO CORP. (NVRO) in Q4 2017, closing a stake of 33,464 shares — an estimated $3.04M sold.

Axiom Investors first reported a position in NVRO in Q1 2017 and held it in 3 quarters. The position peaked at $3.05M in Q1 2017. 194 funds tracked by Wall St. Rank hold NVRO as of Q4 2017.

Axiom Investors reported no remaining NEVRO CORP. position as of Q4 2017 after selling out during the quarter.
Axiom Investors sold 33,464 NEVRO CORP. shares in Q4 2017, an estimated $3.04M.
Axiom Investors first reported a position in NEVRO CORP. in Q1 2017 and held it in 3 quarters.
Axiom Investors's NEVRO CORP. position peaked at $3.05M in Q1 2017.
194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2017.

Based on Axiom Investors's 13F filing for Q4 2017, filed 14 Feb 2018.